multiMED Holdings markets a range of rapid diagnostic tests developed and manufacted by MedMira Labratories, Inc. that are critical tools in preventing and controlling some of today's greatest healthcare challenges, including infectious diseases like HIV and Hepatitis.
Built on MedMira's patented Rapid Flow-Through Technology platform, these tests have achieved 'gold standard' regulatory approvals in the most stringently regulated markets around the world, demonstrating quality and performance time and again.
Unique to the rapid test that we represent is the ability to deliver multiple results on a single test cartridge using a single drop of specimen for human disease detection.
Driven by MedMira's goal to improve healthcare through advanced rapid diagnostics, MedMira is continuously researching new ways to apply RFT technology and have manufactured new RFT tests that are applicable to each country where we distribute.
Most advanced rapid diagnostics
FDA, CE and China approved
Instant results
Easy for mass testing
Single & multiple disease tests
Patented Technology
Decreased costs
A safer world!